Submitted by aabolina on Fri, 03/11/2016 - 12:58
This World Tuberculosis (TB) Day, March 24 2016, the World Health Organization (WHO) is calling for renewed commitments and action in the global fight against TB – one of the world’s top infectious killers. While effective diagnosis and treatment of TB saved an estimated 43 million lives between 2000 and 2014, TB remains one of the world’s biggest threats, with 1.5 million people killed by the disease every year.
Submitted by Lorenzo.Piemonte on Tue, 09/01/2015 - 11:09
Hypoglycaemia in diabetes is often considered to be relevant only to those with type 1 diabetes T1D. Evidence has long been available that hypoglycaemia occurs in people with type 2 diabetes (T2D) using sulphonylureas.
Submitted by Lorenzo.Piemonte on Wed, 07/01/2015 - 14:00
Did you know that every 20 seconds an amputation caused by diabetes occurs somewhere in the world? Paradoxically 85 percent of all amputations caused by diabetes are preventable. If amputation is almost always preventable then this is good news for people at greatest risk for diabetic foot disease. Sadly, amputations are still occurring at too great a rate in high, low- and middle-income countries.
Submitted by Lorenzo.Piemonte on Wed, 07/01/2015 - 13:50
It was 32ºC in the Capital city of Santo Domingo in the Dominican Republic on the day I met Jeffrey, who at 28 had lived with diabetes for 14 years. It was so hot at the Plaza de la Salud General Hospital that volunteers were giving bottles of water to visitors at the front entrance. Jeffrey and I had never met when he appeared in my office and I did not know why he had come for a consultation. He was wet with sweat from the heat outside and I noticed he was not wearing shoes.
Submitted by Lorenzo.Piemonte on Tue, 03/03/2015 - 11:05
La monitorización continua de glucosa (MCG) es una tecnología relativamente nueva que tiene el potencial de ayudar a las personas que viven con diabetes tipo 1 o tipo 2 y son tratadas con insulina a lograr el objetivo de control óptimo de la glucemia.
Submitted by Lorenzo.Piemonte on Tue, 03/03/2015 - 11:00
La surveillance continue de la glycémie (SCG) est une technologie relativement nouvelle qui pourrait aider les personnes atteintes de diabète de type 1 ou de type 2 sous insuline à atteindre l'objectif d'un contrôle optimal de leur glycémie.
Submitted by Lorenzo.Piemonte on Mon, 03/02/2015 - 17:02
Controlar la diabetes tipo 1 y la diabetes tipo 2 lleva mucho tiempo, es complejo y, con frecuencia, difícil. Frecuentemente se detectan síntomas de agotamiento debido al control diabético, ya que muchas personas se sienten a la vez sobrepasadas y vencidas por la diabetes, además de frustradas por la carga que supone el autocontrol diabético.
Submitted by Lorenzo.Piemonte on Mon, 03/02/2015 - 14:27
Continuous Glucose Monitoring (CGM) is a relatively new technology which has the potential to assist people living with type 1 or type 2 diabetes and treated with insulin to achieve the goal of optimum control of blood glucose.
Submitted by Lorenzo.Piemonte on Mon, 03/02/2015 - 14:12
At present, India is facing a dual epidemic of diabetes and tuberculosis (TB). In 2013, there were an estimated 65.1 million people with diabetes and the number is projected to rise to 109 million in 2035.1 Today it is estimated that 80% of all diabetes cases occur in low- and middle-income countries. People with diabetes (type 1 or type 2 diabetes) are at higher risk of contracting TB.
Submitted by aabolina on Tue, 11/25/2014 - 16:32
Según nuestra Encuesta Nacional sobre Salud y Nutrición (ENSANUT) de 2012, aproximadamente siete de cada diez adultos en México sufren sobrepeso. Además, las Estadísticas de Salud de 2014 de la Organización para la Cooperación y el Desarrollo Económicos (OECD) clasifican a México como el segundo país del mundo en prevalencia de obesidad.